ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Everolimus (EVR) versus Mycophenolate Sodium (MPS) for Recipients of Kidney Transplants from Expanded Criteria Donors (ECD) Receiving Anti-Thymocyte Globulin (r-ATG) and Tacrolimus (TAC).

H. Tedesco-Silva,1 C. Felipe,1 A. Brigido,1 A. Bessa,1 M. Paula,1 P. Ruppel,1 M. Cristelli,1 L. Viana,1 G. Basso,1 M. Franco,2 W. Aguiar,1 J. Medina-Pestana.1

1Nephrology Division, Hospital do Rim - UNIFESP, Sao Paulo, Brazil
2Pathology Division, UNIFESP, Sao Paulo, Brazil.

Meeting: 2016 American Transplant Congress

Abstract number: 222

Keywords: Donors, Immunosuppression, Kidney transplantation, marginal

Session Information

Date: Monday, June 13, 2016

Session Name: Concurrent Session: Kidney: Induction Therapy 1

Session Time: 2:30pm-4:00pm

 Presentation Time: 2:54pm-3:06pm

Location: Room 312

Related Abstracts
  • Everolimus Versus Mycophenolate for Recipients of Kidney Transplants from Expanded Criteria Donors (ECD) Receiving Anti-Thymocyte Globulin and Tacrolimus
  • Kinetics of Cytomegalovirus Load in Kidney Transplant Recipients Receiving Everolimus or Mycophenolate Sodium and No Pharmacological Prophylaxis.

Introduction: There is no standard of care immunosuppressive regimen for recipients of kidneys recovered from expanded criteria donors. Several centers use r-ATG induction due to the higher risk of delayed graft function and acute rejection, increasing the risk of CMV infection.

Objectives: This study compares the efficacy and safety of EVR or MPS in ECD kidney transplant recipients. Methods: This is a prospective, randomized, single center study designed to enroll 200 patients (1:1) to receive r-ATG induction (4 doses of 1.5 mg/kg every other day), prednisone, EVR or MPS and delayed introduction of TAC (day 7) to maintaim trough blood concentrations around 5 ng/ml. This preliminary analysis was performed with 127 randomized patients (EVR n=68 and MPS n=59) who completed 6 months of follow up. Preemptive strategy using pp65 antigenemia test was use to manage CMV infection. Results: There were no differences in mean kidney donor profile index (KDPI, 89±9 vs. 89±8%) and mean kidney donor risk index (KDRI, 1.7±0.4 vs. 1.7±0.3) comparing EVR and MPS groups, respectively. There were no differences in main demographic characteristics except for the incidence of diabetes mellitus (EVR, 38% vs. MPS, 15%). There was no difference in incidence of delayed graft function (54 vs. 64%, p=0.253) but duration was lower in MPS group (11.1 ±11.9 vs. 5.0±4.6 days, p= 0.004). The incidence of first CMV infection was lower in EVR group (12 vs. 76%, p=0,000). Furthermore, 36% of patients in MPS (n=21) developed at least one recurrent event of CMV infection. Higher incidence of treated acute rejection (36 vs. 23%, p=0.165) or treated biopsy confirmed acute rejection (18 vs. 10%, p=0.197) was observed in the EVR group. At 6 months mean estimated glomerular filtration rate was higher in the MPS group (MRDR, 38.1±16.2 vs. 48.1±14.8 mL/min, p=0.003). Treatment discontinuation was higher in the MPS group (18% vs. 32%), primarily due to recurrent CMV infections. Conclusions: This preliminary analysis indicates that patients receiving EVR show lower incidence of CMV infection but higher incidence of acute rejection and lower renal function compared to patients receiving MPS.

CITATION INFORMATION: Tedesco-Silva H, Felipe C, Brigido A, Bessa A, Paula M, Ruppel P, Cristelli M, Viana L, Basso G, Franco M, Aguiar W, Medina-Pestana J. Everolimus (EVR) versus Mycophenolate Sodium (MPS) for Recipients of Kidney Transplants from Expanded Criteria Donors (ECD) Receiving Anti-Thymocyte Globulin (r-ATG) and Tacrolimus (TAC). Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Tedesco-Silva H, Felipe C, Brigido A, Bessa A, Paula M, Ruppel P, Cristelli M, Viana L, Basso G, Franco M, Aguiar W, Medina-Pestana J. Everolimus (EVR) versus Mycophenolate Sodium (MPS) for Recipients of Kidney Transplants from Expanded Criteria Donors (ECD) Receiving Anti-Thymocyte Globulin (r-ATG) and Tacrolimus (TAC). [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/everolimus-evr-versus-mycophenolate-sodium-mps-for-recipients-of-kidney-transplants-from-expanded-criteria-donors-ecd-receiving-anti-thymocyte-globulin-r-atg-and-tacrolimus-tac/. Accessed March 1, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Left-Sided Donor Nephrectomy Predisposes Living Kidney Donors to Latent Adrenal Insufficiency with Symptoms of Fatigue and Inferior Quality of Life.
  • Home
  • Search
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.